Longitudinal Study of Brain Amyloid imaGing in MEMENTO

PHASE3CompletedINTERVENTIONAL
Enrollment

448

Participants

Timeline

Start Date

June 10, 2014

Primary Completion Date

October 9, 2019

Study Completion Date

October 9, 2019

Conditions
Alzheimer's Disease (AD) and Related Disorders
Interventions
DRUG

Flutemetamol (18F)

DRUG

Florbetapir (18F)

Trial Locations (26)

33000

CHU de Bordeaux - Pellegrin, Bordeaux

Unknown

CHU d'Angers, Angers

CHU de Besançon, Besançon

AP-HP - Avicenne, Bobigny

CHU de Bordeaux - Hôpital Xavier-Arnozan, Bordeaux

CHU de Brest, Brest

CHU de Clermont-Ferrand, Clermont-Ferrand

CHU de Dijon, Dijon

CHU de Grenoble, Grenoble

CHU de Lille, Lille

Hospices civils de Lyon, Lyon

AP-HM, Marseille

CHU de Montpellier, Montpellier

CHU de Nancy, Nancy

CHU de Nice, Nice

AP-HP - Hôpital BROCA, Paris

AP-HP - Hôpital LARIBOISIERE, Paris

Ap-Hp La Pitié-Salpêtrière, Paris

CHU de Poitiers, Poitiers

CHU de Rouen, Rouen

CHU de Saint-Etienne - Hôpital de la charité, Saint-Etienne

CHU de Saint-Etienne - Hôpital Nord, Saint-Etienne

CHU de Strasbourg, Strasbourg

CHU de Toulouse - Hôpital Purpan, Toulouse

CHU de Toulouse, Toulouse

CHU de Tours, Tours

All Listed Sponsors
collaborator

Fondation Plan Alzheimer

OTHER

collaborator

GE Healthcare

INDUSTRY

collaborator

Avid Radiopharmaceuticals

INDUSTRY

lead

University Hospital, Bordeaux

OTHER